Related references
Note: Only part of the references are listed.Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer
Willie Wilson et al.
CANCER RESEARCH (2008)
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Han C. Dan et al.
GENES & DEVELOPMENT (2008)
The IκB kinase complex: master regulator of NF-κB signaling
Laura A. Solt et al.
IMMUNOLOGIC RESEARCH (2008)
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
P. Arora et al.
ONCOGENE (2008)
Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
D. Bhaumik et al.
ONCOGENE (2008)
Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
Qing-Bai She et al.
PLOS ONE (2008)
Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screen
Lloyd T. Lam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
IκB kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells
Yixue Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nuclear factor-κB activation:: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
Sindhu Singh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Priti S. Hegde et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R. L. Dillon et al.
ONCOGENE (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease
S Papa et al.
CELL DEATH AND DIFFERENTIATION (2006)
Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription
KA Steinbrecher et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Effects of the EGFR/HER2 kinase inhibitor gw572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance
H Zhou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The two NF-κB activation pathways and their role in innate and adaptive immunity
G Bonizzi et al.
TRENDS IN IMMUNOLOGY (2004)
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
YM Li et al.
CANCER CELL (2004)
Upregulation of IKKα/IKKβ by integrin-linked kinase is required for HER2/neu-induced NF-κB antiapoptotic pathway
K Makino et al.
ONCOGENE (2004)
Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway
F Weih et al.
IMMUNOLOGICAL REVIEWS (2003)
NIK is a component of the EGF/heregulin receptor signaling complexes
DY Chen et al.
ONCOGENE (2003)
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells
C Knuefermann et al.
ONCOGENE (2003)
Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
WL Xia et al.
ONCOGENE (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-κB (NF-κB)-inducing kinase to activate NF-κB -: Identification of a novel receptor-tyrosine kinase signalosome
AA Habib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of Iκ-B-α that can be inhibited by the tumor suppressor PTEN
S Pianetti et al.
ONCOGENE (2001)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
Share Paper
